P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection

Perlstein, Itay; Wagner, A. Merenlender; Lamson, Michael; Spiegelstein, Ofer; Loupe, Pippa S.; Goméni, Roberto; Elgart, Anna

doi:10.1016/j.euroneuro.2021.10.434

European Neuropsychopharmacology

2021

DOI: 10.1016/j.euroneuro.2021.10.434

|View full text |Cite

P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection

Itay Perlstein¹,

A. Merenlender Wagner

Michael Lamson³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

Kane,

Harary,

Eshet

et al. 2023

The Lancet Psychiatry

View full text Add to dashboard Cite

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

Kane,

Harary,

Eshet

et al. 2023

The Lancet Psychiatry

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

P.0461 Population pharmacokinetic modeling and simulation to guide dose selection for TV-46000, a new long-acting formulation of risperidone for subcutaneous injection

Cited by 1 publication

References 1 publication

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

Contact Info

Product

Resources

About